However, AKT overexpression partly reduced the inhibitory effects of lomerizine 2HCl on the AKT/mTOR signaling pathway and weakened the inhibitory actions of lomerizine 2HCl on CRC cell growth. The gene discussed is AKT1; the disease is colorectal carcinoma.